Immunomodulatory role of metalloproteases in cancers: Current progress and future trends

Metalloproteinases (MPs) is a large family of proteinases with metal ions in their active centers. According to the different domains metalloproteinases can be divided into a variety of subtypes mainly including Matrix Metalloproteinases (MMPs), A Disintegrin and Metalloproteases (ADAMs) and ADAMs w...

Full description

Bibliographic Details
Main Authors: Qi Wang, Kai Wang, Xiaojing Tan, Zhenxiang Li, Haiyong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1064033/full
_version_ 1797980777667887104
author Qi Wang
Kai Wang
Xiaojing Tan
Zhenxiang Li
Haiyong Wang
author_facet Qi Wang
Kai Wang
Xiaojing Tan
Zhenxiang Li
Haiyong Wang
author_sort Qi Wang
collection DOAJ
description Metalloproteinases (MPs) is a large family of proteinases with metal ions in their active centers. According to the different domains metalloproteinases can be divided into a variety of subtypes mainly including Matrix Metalloproteinases (MMPs), A Disintegrin and Metalloproteases (ADAMs) and ADAMs with Thrombospondin Motifs (ADAMTS). They have various functions such as protein hydrolysis, cell adhesion and remodeling of extracellular matrix. Metalloproteinases expressed in multiple types of cancers and participate in many pathological processes involving tumor genesis and development, invasion and metastasis by regulating signal transduction and tumor microenvironment. In this review, based on the current research progress, we summarized the structure of MPs, their expression and especially immunomodulatory role and mechanisms in cancers. Additionally, a relevant and timely update of recent advances and future directions were provided for the diagnosis and immunotherapy targeting MPs in cancers.
first_indexed 2024-04-11T05:59:10Z
format Article
id doaj.art-e1f0a81617cc4ab6bd6df72c0ab6ee05
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T05:59:10Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e1f0a81617cc4ab6bd6df72c0ab6ee052022-12-22T04:41:48ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-12-011310.3389/fimmu.2022.10640331064033Immunomodulatory role of metalloproteases in cancers: Current progress and future trendsQi Wang0Kai Wang1Xiaojing Tan2Zhenxiang Li3Haiyong Wang4Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaKey Laboratory of Epigenetics and Oncology, Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, ChinaDepartment of Oncology, Dongying People's Hospital, Dongying, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaMetalloproteinases (MPs) is a large family of proteinases with metal ions in their active centers. According to the different domains metalloproteinases can be divided into a variety of subtypes mainly including Matrix Metalloproteinases (MMPs), A Disintegrin and Metalloproteases (ADAMs) and ADAMs with Thrombospondin Motifs (ADAMTS). They have various functions such as protein hydrolysis, cell adhesion and remodeling of extracellular matrix. Metalloproteinases expressed in multiple types of cancers and participate in many pathological processes involving tumor genesis and development, invasion and metastasis by regulating signal transduction and tumor microenvironment. In this review, based on the current research progress, we summarized the structure of MPs, their expression and especially immunomodulatory role and mechanisms in cancers. Additionally, a relevant and timely update of recent advances and future directions were provided for the diagnosis and immunotherapy targeting MPs in cancers.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1064033/fullmetalloproteasesimmunomodulatorycancersdiagnosistherapy
spellingShingle Qi Wang
Kai Wang
Xiaojing Tan
Zhenxiang Li
Haiyong Wang
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
Frontiers in Immunology
metalloproteases
immunomodulatory
cancers
diagnosis
therapy
title Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
title_full Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
title_fullStr Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
title_full_unstemmed Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
title_short Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
title_sort immunomodulatory role of metalloproteases in cancers current progress and future trends
topic metalloproteases
immunomodulatory
cancers
diagnosis
therapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1064033/full
work_keys_str_mv AT qiwang immunomodulatoryroleofmetalloproteasesincancerscurrentprogressandfuturetrends
AT kaiwang immunomodulatoryroleofmetalloproteasesincancerscurrentprogressandfuturetrends
AT xiaojingtan immunomodulatoryroleofmetalloproteasesincancerscurrentprogressandfuturetrends
AT zhenxiangli immunomodulatoryroleofmetalloproteasesincancerscurrentprogressandfuturetrends
AT haiyongwang immunomodulatoryroleofmetalloproteasesincancerscurrentprogressandfuturetrends